4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-22-026150
Options or other derivatives
- SVP and Chief Development Off. acquired 5,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Pavliv Leo SVP and Chief Development Off. | 2022-03-16 | Grant or award · Options (right to buy) | +5,000 | 5,000 | D | ||
Loading xslF345X03/doc4.xml…